Cardiol Therapeutics (CRDL) Other Non Operating Income (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Other Non Operating Income came in at $158237.6 in Q1 2026, up 312.48% YoY from $38362.5 in Q1 2025, and up 171.52% on a QoQ basis from -$221254.1 in Q4 2025.
Cardiol Therapeutics (CRDL) Other Non Operating Income (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Other Non Operating Income data on file, last reported at $158237.6 in Q1 2026.
- Quarterly Other Non Operating Income rose 312.48% year-over-year to $158237.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$614894.7 (down 161.07% YoY) and the FY2025 annual result came in at -$846679.6, down 155.28% from the prior year.
- Other Non Operating Income rose to $158237.6 in Q1 2026, from -$221254.1 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q3 2022 to a low of -$1.1 million in Q1 2022.
- A 5-year average of $145123.3 and a median of $56802.8 in 2023 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 2201.1% in 2022, down 2657.74% in 2022.
- Tracing CRDL's Other Non Operating Income over 5 years: stood at -$389210.5 in 2022, then decreased by 18.55% to -$461397.0 in 2023, then soared by 332.83% to $1.1 million in 2024, then sank by 120.6% to -$221254.1 in 2025, then surged by 171.52% to $158237.6 in 2026.
- The last three Other Non Operating Income figures came in at $158237.6 (Q1 2026), -$221254.1 (Q4 2025), and $67986.2 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,237.64 |
| Dec 31, 2025 | -221,254.10 |
| Sep 30, 2025 | 67,986.15 |
| Jun 30, 2025 | -619,864.43 |
| Mar 31, 2025 | -74,471.80 |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -104,117.78 |
| Jun 30, 2024 | 111,145.79 |
| Mar 31, 2024 | 466,740.97 |
| Dec 31, 2023 | -461,397.02 |
| Sep 30, 2023 | 497,944.39 |
| Jun 30, 2023 | -617,083.35 |
| Mar 31, 2023 | 56,802.76 |
| Dec 31, 2022 | -389,210.48 |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | -1.08 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 98,992.93 |
| Jun 30, 2021 | -132,697.67 |